Medimaster Pharmaceuticals Profile
Key Indicators
- Authorised Capital ₹ 1.45 M
as on 30-12-2024
- Paid Up Capital ₹ 0.50 M
as on 30-12-2024
- Company Age 4 Year, 6 Months
- Last Filing with ROC 31 Mar 2021
- Satisfied Charges ₹ 1.10 M
as on 30-12-2024
About Medimaster Pharmaceuticals
The Company is engaged in the Trading Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2021. It's a company limited by shares with an authorized capital of Rs 1.45 M and a paid-up capital of Rs 0.50 M.
The company has closed loans amounting to ₹1.10 M, and has no open charges as per Ministry of Corporate Affairs (MCA) records.
Naveen Gupta, Sonam Kishore, and Mohammad Khan serve as directors at the Company.
- CIN/LLPIN
U51909BR2020PTC046632
- Company No.
046632
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
04 Jul 2020
- Date of AGM
31 Dec 2021
- Date of Balance Sheet
31 Mar 2021
- Listing Status
Unlisted
- ROC Code
Roc Patna
Industry
Company Details
- Location
Champaran, Bihar, India
- Telephone
- Email Address
- Website
-
- Social Media-
Who are the key members and board of directors at Medimaster Pharmaceuticals?
Board Members (3)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Naveen Gupta  | Director | 11-Mar-2023 | Current |
| Sonam Kishore | Director | 04-Jul-2020 | Current |
| Mohammad Khan | Director | 04-Jul-2020 | Current |
Financial Performance of Medimaster Pharmaceuticals.
Enhance accessibility to Medimaster Pharmaceuticals's financial data by unlocking access to both Standalone and Consolidated balance sheets, Profit & Loss Statements, Ratios, Related Party Transactions, and additional relevant information.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metrics |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue | |||||||
| Revenue from Operations | |||||||
| Total Assets | |||||||
| Profit or Loss | |||||||
| Net Worth | |||||||
| EBITDA |
What is the Ownership and Shareholding Structure of Medimaster Pharmaceuticals?
Unlock access to Medimaster Pharmaceuticals's control and ownership data, Corporate Shareholding Patterns, Funding (security allotment) details, Foreign Institutional Investor information, Directors and Key Management Personnel (KMP) Remuneration, Group Structure, Overseas Direct Investment and other pertinent data.
Related Corporates (Common Directorship)
Charges (Loans)
₹0
₹1.10 M
Charges Breakdown by Lending Institutions
- Canara Bank : 0.11 Cr
Latest Charge Details
| Date | Lender | Amount | Status |
|---|---|---|---|
| 29 May 2021 | Canara Bank | ₹1.10 M | Satisfied |
How Many Employees Work at Medimaster Pharmaceuticals?
Medimaster Pharmaceuticals has a workforce of 0 employees as of Mar 28, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Medimaster Pharmaceuticals, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Medimaster Pharmaceuticals's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
